Zobrazeno 1 - 10
of 219
pro vyhledávání: '"Tien‐Hsing Chen"'
Autor:
Dong‐Yi Chen, Chun‐Chi Chen, Cheng‐Hung Lee, Chi‐Nan Tseng, Shao‐Wei Chen, Shang‐Hung Chang, Tien‐Hsing Chen, Pao‐Hsien Chu, I‐Chang Hsieh, Ming‐Shien Wen, Ming‐Lung Tsai, Ming‐Jer Hsieh
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2259-2271 (2024)
Abstract Aims The PIONEER‐HF and PARAGLIDE‐HF trials aimed to determine the efficacy and safety of the in‐hospital initiation of sacubitril/valsartan in patients hospitalized for AHF. However, whether the inclusion and exclusion criteria of the
Externí odkaz:
https://doaj.org/article/3df3cbf84add40b389c311b6a71fb639
Autor:
Ming-Shyan Lin, Po-Chang Wang, Meng-Hung Lin, Ting-Yu Kuo, Yu-Sheng Lin, Tien-Hsing Chen, Ming-Horng Tsai, Yao-Hsu Yang, Chun-Liang Lin, Chang-Min Chung, Pao-Hsien Chu
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Little research has been done on ischemic outcomes related to left ventricular ejection fraction (EF) in acute decompensated heart failure (ADHF). Methods A retrospective cohort study was conducted between 2001 and 2021 using the
Externí odkaz:
https://doaj.org/article/8fd3039c0c4b45d5a4b7ce916e5da17a
Autor:
Ming-Lung Tsai, Yuan Lin, Ming-Shyan Lin, Tzu-Hsien Tsai, Ning-I Yang, Chao-Yung Wang, I-Chang Hsieh, Ming-Jui Hung, Tien-Hsing Chen
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background and aims Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) treatment in patients with HFrEF and T2DM are limited. This study evaluated the clinical
Externí odkaz:
https://doaj.org/article/50681a385e1f4a9a89c36429eaa0c8c7
Autor:
Yuan Lin, Te-Hsiung Wang, Ming-Lung Tsai, Victor Chien-Chia Wu, Chin-Ju Tseng, Ming-Shyan Lin, Yan-Rong Li, Chih-Hsiang Chang, Tien-Shin Chou, Tzu-Hsien Tsai, Ning-I Yang, Ming-Jui Hung, Tien-Hsing Chen
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background To determine whether glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular and renal protective effects in patients with advanced diabetic kidney disease (DKD) with an estimated glomerular filtration rate (eGFR)
Externí odkaz:
https://doaj.org/article/28ce83582cd14ad9a80819fa3b02b39a
Publikováno v:
Medicina, Vol 60, Iss 3, p 357 (2024)
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used to reduce glucose levels in patients with type 2 diabetes mellitus since 2005. This meta-analysis discusses the mechanisms and potential benefits of several GLP-1 RAs. In particular
Externí odkaz:
https://doaj.org/article/743439a64b68458e861046394e95a607
Autor:
Hsuan-Ching Lin, Ming-Jui Hung, Chao-Hung Wang, Tien-Hsing Chen, Wei-Siang Chen, Chi-Wen Cheng
Publikováno v:
Medicina, Vol 59, Iss 8, p 1499 (2023)
Background and Objectives: The demand for permanent pacemaker (PPM) implantation for extremely old patients is increasing. Prior to implanting PPMs, life expectancy evaluation is essential but difficult. We aimed to develop and validate a scoring sys
Externí odkaz:
https://doaj.org/article/1464ee9ee7b14c20b45742e51f7df922
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
PurposeTo investigate the risk and protective factors of dry eye disease (DED) in patients with type II diabetes mellitus (DM).DesignA retrospective cohort study using Chang- Gung research database collecting data from 2005 to 2020.MethodsPatients wi
Externí odkaz:
https://doaj.org/article/06cf6a05e6e443af9554ff71bd879745
Autor:
Po-Chang Wang, Tien-Hsing Chen, Chang-Min Chung, Mei-Yen Chen, Jung-Jung Chang, Yu-Sheng Lin, Pao-Hsien Chu, Yun-Shing Peng, Ming-Shyan Lin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Little is known about the association between deep vein thrombosis (DVT) and arterial complications in patients with type 2 diabetes (T2DM). The aim of this retrospective cohort study was to assess the influence of prior DVT on major adverse
Externí odkaz:
https://doaj.org/article/58c42ebd677b4dafaccf56a03803ca8c
Autor:
Yu-Cheng Kao, Tien-Hsing Chen, Chi-Hung Liu, Jawl-Shan Hwang, Ching-Chung Hsiao, Yu-Sheng Lin, Chun-Tai Mao, Ming-Jui Hung, Yan-Rong Li
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Atorvastatin 40 mg (ATOR 40) and ezetimibe 10 mg/simvastatin 20 mg (EZ-SIM 20) have similar reductions of low-density lipoprotein cholesterol (LDL-C) but cardiovascular (CV) outcomes between these two therapies are unclear. Our real-world co
Externí odkaz:
https://doaj.org/article/d4191a5e624647d6b01ef66502373c4b
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Diabetes mellitus is a known risk factor for infection. Pay for Performance (P4P) program is designed to enhance the comprehensive patient care. The aim of this study is to evaluate the effect of the P4P program on infection incid
Externí odkaz:
https://doaj.org/article/a8911d87a02041b19cfbd4f77a3da5b4